Detection of immunoreactive schizophyllan by solid-phase enzyme-linked immunosorbent assay

Area of Science:

• Immunology
• Biochemistry
• Analytical Chemistry

Background:

• Schizophyllan (SPG) is a beta-1,3-glucan with potential biological activities.
• Accurate detection and quantification methods are crucial for studying SPG.
• Existing methods may have limitations in sensitivity or applicability.

Purpose of the Study:

• To develop and validate a sensitive enzyme-linked immunosorbent assay (ELISA) for detecting immunoreactive schizophyllan (SPG).
• To establish a method for quantifying SPG in various antigen conjugates and biological samples.

Main Methods:

• Development of a solid-phase ELISA using a murine anti-schizophyllan monoclonal antibody (SPG1-HS).
• Preparation of schizophyllan-bovine serum albumin (SPG-BSA) and schizophyllan-bovine hemoglobin (SPG-Hb) conjugates as antigens.
• Measurement of absorbance at 490 nm to correlate with SPG concentration.

Main Results:

• The ELISA showed a direct proportionality between absorbance at 490 nm and SPG concentration.
• Accurate SPG measurement was achieved at concentrations above 1.0 microgram/ml in SPG-BSA and SPG-Hb conjugates.
• The developed ELISA successfully detected SPG in human serum samples conjugated with SPG-BSA and SPG-Hb.

Conclusions:

• The established ELISA method is effective for the accurate determination of schizophyllan (SPG) concentration.
• This assay is applicable for quantifying SPG in SPG-BSA and SPG-Hb conjugates within human tissue and blood samples.
• The findings support the utility of this ELISA in immunological and biochemical studies involving schizophyllan.